Drug Profile
OC 060062
Latest Information Update: 10 Apr 2003
Price :
$50
*
At a glance
- Originator Ontogen
- Class
- Mechanism of Action Protein-tyrosine-phosphatase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Diabetes mellitus
Most Recent Events
- 10 Apr 2003 No development reported - Preclinical for Diabetes mellitus in USA (unspecified route)
- 03 Aug 2000 Preclinical development for Diabetes mellitus in USA (Unknown route)